For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
Dec 01, 2022•9 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android